Regeneron Is 'One Of The Stronger Growers In Biotech' By: Benzinga via Benzinga June 29, 2016 at 15:04 PM EDT Bernstein has initiated coverage of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) with an Outperform rating and $400 price target, citing ... Read More >> Related Stocks: Amgen Novartis Ag ADR Regeneron Pharmaceuticals